August 2022 - CannabisNewsWire

WednesdayAug 31, 2022 4:20 pm

420 with CNW — Swiss Government to Launch Trial Cannabis Sales Program

Switzerland is set to become the first nation in Europe to launch a marijuana sales pilot program. The program, called Weed Care, will help study the effects of the legalization of marijuana. It will be launched officially on Sept. 15, 2022, and will run until March 2025. Weed Care involves 370 participants based in Basel, the third most populous city in the country. All participants involved in the program reside in the city, are aged 18 and above, and are already consumers of cannabis. Throughout the study period, every participant will undergo regular assessments of their mental and physical health…

WednesdayAug 31, 2022 12:15 pm

REZYFi, Inc. Is ‘One to Watch’

REZYFi Lending sees higher margin lending opportunities as well as significant market opportunity to provide the growing and underserved cannabis industry with financial services ResMac forecasts $285 million in retail loan origination in 2023 and foresees strong growth opportunities ResMac is on pace to originate $250 million in wholesale loan business in 2023, with its year-over-year credit facility increase expected to jump more than 300% The company’s management team has more than 40 years’ experience in the mortgage and lending industry REZYFi expects to operate nationwide by the end of 2022; it currently operates in 34 states REZYFi is a…

WednesdayAug 31, 2022 4:20 am

420 with CNW — Oklahoma Voters May Not Decide Fate of Cannabis Measure Despite Ample Signature Submission

Voters in Oklahoma may not get the chance to vote on cannabis legalization during the upcoming November ballot even though reform activists behind a cannabis legalization measure collected enough signatures. Even though state officials confirmed that activists had reached the signature threshold, the campaign still needs to fulfill a few formalities before the deadline for printing voting materials passes. Last month, the Oklahomans for Sensible Marijuana Laws (OSML) campaign announced that it had submitted more than 164,000 signatures to the Oklahoma secretary of state’s office, surpassing the signature threshold that was needed by more than 50,000 signatures. The campaign’s initiative…

TuesdayAug 30, 2022 4:20 pm

420 with CNW — How Missouri Activists Overcame Setbacks to Put Cannabis Measure on Upcoming Ballot

Cannabis reform activists in Missouri have managed to get their legalization bill on the November ballot after being bogged down by setbacks and nearly forced to give up on their bill. According to unofficial tallies, the Legal Missouri campaign had not collected enough signatures to qualify for the upcoming ballot by late July, being 2,275 signatures short. With the ballot fast approaching, many feared the campaign's hope of gathering enough signatures in time would be dashed. But activists behind the campaign managed to pull a major comeback, collecting the remaining 2,275 signatures by Aug. 9, 2022, and qualifying the legalization…

TuesdayAug 30, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces the Availability of a Broadcast titled, “The Power of Science to Stop a Killer”

Lexaria’s latest broadcast highlights the company’s progress in finding a potential solution for hypertension treatment while also pointing out why such a solution is much needed at this point Since the company began developing its patented DehydraTECH(TM) technology in 2014, it has made significant progress in its clinical studies, even as it currently focuses on human clinical research to evaluate the tolerability, safety, and efficacy of its solution for hypertension treatment Lexaria expressed its confidence in its proposed solution, noting that it will not only be a safer but also better-tolerated drug candidate, unlike current alternatives in the market whose…

TuesdayAug 30, 2022 4:20 am

420 with CNW — Recent Studies Show Advanced Cancer Sufferers Could Benefit from Using Marijuana

Over the past couple of years, a surge in cannabis research has revealed that the controversial plant has a variety of medical applications. Despite being classified as a Schedule I drug with no medical application, studies have found that cannabis can be effective at alleviating conditions such as chronic pain, depression and insomnia. Furthermore, the U.S. Food and Drug Administration has also approved a CBD-based drug called Epidiolex to treat seizures in pediatric epilepsy. In recent months, research into the impact of cannabis on cancer treatment has found that the plant can have a positive impact on cancer patients. Cancer…

MondayAug 29, 2022 4:20 pm

420 with CNW — Marijuana Firms in Virginia Expand Facilities Despite Uncertainty Over Recreational Sales

Last year, legislators in Virginia approved a measure to legalize its commercial recreational cannabis market and launch it in 2024, which would make it the first of its kind in the South. At the time, Democrats were in control of the state’s government. However, once Republicans reclaimed the governor’s mansion and the House of Delegates in November, whether the state’s adult-use program would actually be launched at the stipulated time was thrown into disarray. Despite this, marijuana multistate operators remain focused on expanding their medical cannabis facilities. For instance, representatives from Columbia Care and Jushi Holdings have revealed that their…

MondayAug 29, 2022 9:00 am

AROYA Crop Steering Expertise and Technology Provides Data-Driven Insights, Automation and Competitive Advantage for Successful Harvests

For cannabis operators, crop steering directs how their plants grow as well as their literal shape. Knowing how and when to manipulate light, climate and irrigation – the three foundational components of crop steering – is essential to balancing high yields and high quality. Why do successful growers – from small craft farmers to the largest multistate operators – use data-driven and automated crop steering solutions? Because even the slightest adjustments to any number of factors can have huge effects on grows. Data is the lifeblood of a plant growers, providing the intelligence to track how and when plants change…

MondayAug 29, 2022 4:20 am

420 with CNW — Experts Say Federal Court Ruling in Maine Could Pave Way for Interstate Cannabis Commerce

Last week, a federal appellate court ruled that the law prohibiting nonresidents in Maine from owning medical cannabis businesses in the state violated the United States’ constitution. Stakeholders in the industry have been monitoring the case keenly, with many arguing that the dormant commerce clause of the constitution applies to the cannabis industry, despite ongoing federal marijuana prohibition. Legal experts believe that this ruling may have extensive implications for interstate marijuana commerce, with some noting that it could create potential complications for social equity programs. In the 2 to 1 ruling, the U.S. Court of Appeals for the First Circuit…

FridayAug 26, 2022 4:20 pm

420 with CNW — DOT Tables New Guidelines on CBD on the Certification of Commercial Drivers

The cannabidiol (CBD) revolution has been fantastic to behold. In just a few short years, the cannabis extract went from virtual anonymity to being one of the most searched-for items on the web. CBD is said to have a plethora of medical applications, including alleviating anxiety, chronic pain and insomnia, and it has been subject to significant consumer and scientific interest in recent years. However, cannabidiol use is still frowned upon by plenty of employers, including the federal government. This is despite the fact that unlike delta-9 THC, the main psychoactive agent in cannabis, CBD does not intoxicate users. In…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

Month: August 2022